Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACB
2876
PUT
Aurora Cannabis
ACB
$233M
| $5.13M | ﹤0.01% |
5,462
-3,622
| -40% | -$3.64M |
|
2877
Vanguard Dividend Appreciation ETF
VIG
$114B
| $5.12M | ﹤0.01% |
44,486
-13,488
| -23% | -$1.51M |
|
2878
United Parks & Resorts
PRKS
$2.04B
| $5.12M | ﹤0.01% |
165,081
-1,014,740
| -86% | -$27.9M |
|
2879
PUT
Neurocrine Biosciences
NBIX
$15.5B
| $5.12M | ﹤0.01% |
60,600
-11,500
| -16% | -$944K |
|
2880
PUT
Keysight
KEYS
$61.1B
| $5.11M | ﹤0.01% |
56,900
-10,400
| -15% | -$883K |
|
2881
PUT
Textron
TXT
$15.3B
| $5.1M | ﹤0.01% |
96,100
+45,000
| +88% | +$2.28M |
|
2882
iShares International Equity Factor ETF
INTF
$3.77B
| $5.09M | ﹤0.01% |
+193,952
| New | +$5.09M |
|
2883
PUT
Plains All American Pipeline
PAA
$16.9B
| $5.09M | ﹤0.01% |
208,900
+74,900
| +56% | +$1.79M |
|
2884
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.6B
| $5.08M | ﹤0.01% |
+45,661
| New | +$5M |
|
|
MIC
2885
PUT
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $5.08M | ﹤0.01% |
125,400
-34,900
| -22% | -$1.43M |
|
2886
CALL
Essex Property Trust
ESS
$18.5B
| $5.08M | ﹤0.01% |
17,400
-6,700
| -28% | -$1.93M |
|
|
NVO
2887
PUT
Novo Nordisk
NVO
$201B
| $5.08M | ﹤0.01% |
199,000
-17,200
| -8% | -$425K |
|
2888
PUT
Agilent Technologies
A
$41.9B
| $5.07M | ﹤0.01% |
67,900
+10,900
| +19% | +$808K |
|
2889
CALL
Ollie's Bargain Outlet
OLLI
$4.62B
| $5.06M | ﹤0.01% |
58,100
+2,800
| +5% | +$264K |
|
2890
CALL
ProShares UltraPro Dow 30
UDOW
$924M
| $5.05M | ﹤0.01% |
196,800
-81,200
| -29% | -$1.99M |
|
2891
AtriCure
ATRC
$2.25B
| $5.05M | ﹤0.01% |
169,280
-46,214
| -21% | -$1.35M |
|
2892
CALL
PACCAR
PCAR
$68.8B
| $5.05M | ﹤0.01% |
105,750
+9,750
| +10% | +$453K |
|
2893
Progress Software
PRGS
$1.79B
| $5.05M | ﹤0.01% |
115,809
-54,434
| -32% | -$2.36M |
|
2894
Bio-Rad Laboratories Class A
BIO
$9.53B
| $5.05M | ﹤0.01% |
16,155
-25,830
| -62% | -$7.73M |
|
|
WUBA
2895
DELISTED
58.com Inc
WUBA
| $5.05M | ﹤0.01% |
81,227
-87,532
| -52% | -$5.64M |
|
|
INVX
2896
Innovex International
INVX
$2.18B
| $5.05M | ﹤0.01% |
105,158
-210,898
| -67% | -$9.17M |
|
2897
Nuveen Enhanced Yield US Aggregate Bond ETF
NUAG
$96.6M
| $5.05M | ﹤0.01% |
205,879
+191,309
| +1,313% | +$4.6M |
|
2898
Lithia Motors
LAD
$8.3B
| $5.04M | ﹤0.01% |
42,455
+918
| +2% | +$102K |
|
2899
Kiniksa Pharmaceuticals
KNSA
$5.99B
| $5.04M | ﹤0.01% |
372,287
+246,442
| +196% | +$3.82M |
|
2900
National Presto Industries
NPK
$1B
| $5.04M | ﹤0.01% |
54,044
+4,842
| +10% | +$493K |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.